|
RANBP9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.037090E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.200800E-04 |
| Normal-vs-Stage2 |
1.785380E-01 |
| Normal-vs-Stage3 |
9.256400E-02 |
| Normal-vs-Stage4 |
1.061930E-02 |
| Stage1-vs-Stage2 |
3.314600E-01 |
| Stage1-vs-Stage3 |
1.530360E-01 |
| Stage1-vs-Stage4 |
9.693000E-01 |
| Stage2-vs-Stage3 |
9.454200E-01 |
| Stage2-vs-Stage4 |
4.010800E-01 |
| Stage3-vs-Stage4 |
2.871800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.282430E-03 |
| Normal-vs-AfricanAmerican |
2.052100E-02 |
| Normal-vs-Asian |
4.859000E-03 |
| Caucasian-vs-AfricanAmerican |
3.727600E-01 |
| Caucasian-vs-Asian |
4.777400E-01 |
| AfricanAmerican-vs-Asian |
7.459800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.982800E-03 |
| Normal-vs-Female |
1.540560E-03 |
| Male-vs-Female |
9.563200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.366470E-04 |
| Normal-vs-Age(41-60Yrs) |
2.533900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.491780E-01 |
| Normal-vs-Age(81-100Yrs) |
7.977800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.676300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.788300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.374400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.635600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.658600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.211000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.618000E-01 |
| Classical-VS-Follicular |
2.03929999997854E-07 |
| Classical-VS-Other |
1.808010E-01 |
| Classical-VS-Normal |
4.75310000003226E-06 |
| Tall-VS-Follicular |
6.556000E-03 |
| Tall-VS-Other |
2.617000E-01 |
| Tall-VS-Normal |
9.282600E-03 |
| Follicular-VS-Other |
7.251000E-01 |
| Follicular-VS-Normal |
5.551000E-01 |
| Other-VS-Normal |
8.742600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.846010E-01 |
| Normal-vs-N1 |
1.469440E-01 |
| N0-vs-N1 |
5.945000E-01 |
|
|
